发明名称 |
Viral adjuvants |
摘要 |
The present invention provides viral adjuvants for enhancing an immune response to an immunogen. In particular embodiments, the viral adjuvant is an alphavirus adjuvant or a Venezuelan Equine Encephalitis viral adjuvant. Also provided are compositions comprising the viral adjuvant and an immunogen, and pharmaceutical formulations comprising the viral adjuvant or compositions of the invention in a pharmaceutically acceptable carrier. Further provided are methods of producing an immune response against an immunogen in a subject comprising administering the immunogen and a viral adjuvant of the invention to the subject. |
申请公布号 |
US8821897(B2) |
申请公布日期 |
2014.09.02 |
申请号 |
US201012954021 |
申请日期 |
2010.11.24 |
申请人 |
The University of North Carolina at Chapel Hill |
发明人 |
Johnston Robert E.;Thompson Joseph M. |
分类号 |
A61K39/39;A61K39/193;A61K39/12;C07K14/005;A61K39/145;A61K39/00 |
主分类号 |
A61K39/39 |
代理机构 |
Myers Bigel Sibley & Sajovec, P.A. |
代理人 |
Myers Bigel Sibley & Sajovec, P.A. |
主权项 |
1. An alphavirus adjuvant comprising:
a modified alphavirus genomic nucleic acid that lacks sequences encoding the alphavirus structural proteins required for production of new alphavirus particles; wherein the modified alphavirus genome does not comprise a heterologous nucleic acid sequence that encodes a polypeptide of interest or a functional untranslated RNA and the 26S promoter is inactivated or deleted. |
地址 |
Chapel Hill NC US |